Thomas Patrick Kelly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 23,100 shares at $58.16 ($1.3M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Open-market sale of $1.3M DCPH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.54 | 5,360 | $308K | 23.2% |
| 2 | $57.54 | 5,360 | $308K | 23.2% |
| 3 | $58.16 | 1,981 | $115K | 8.7% |
| 4 | $58.16 | 1,981 | $115K | 8.7% |
| 5 | $59.48 | 200 | $12K | 0.9% |
| 6 | $62.25 | 100 |
| $6K |
| 0.5% |
| 7 | $56.26 | 500 | $28K | 2.1% |
| 8 | $57.22 | 2,793 | $160K | 12.0% |
| 9 | $57.22 | 2,793 | $160K | 12.0% |
| 10 | $58.14 | 966 | $56K | 4.2% |
| 11 | $58.14 | 966 | $56K | 4.2% |
| 12 | $58.74 | 100 | $6K | 0.4% |
| Total | $57.63 avg | 23,100 | $1.3M | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |